Essential Thrombocythemia Market - Top Companies and Manufacturers

Companies Dominating the Essential Thrombocythemia Landscape

Active Biotech AB
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Incyte
Bayer AG
USV Private Limited.
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Eli Lilly and Company
AstraZeneca
Takeda Pharmaceutical Company Limited

Browse Key Market Insights with Data Illustration:

Essential Thrombocythemia Market Size Forecasts 2025-2037

In the News

Active Biotech AB announced the approval for tasquinimod Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of myelofibrosis. It creates an important regulatory channel and gives us the opportunity to rapidly progress tasquinimod development in this patient population.
Incyte has announced to receive data from two Limber trials assessing single-agent therapy and combination treatments in patients with myelofibrosis (MF) using ruxolitinib with parsaclisib.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of essential thrombocythemia is assessed at USD 1.01 billion.

The essential thrombocythemia market size was valued at USD 921.57 million in 2024 and is expected to reach USD 1.91 billion by 2037, expanding at around 5.8% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of essential thrombocythemia, and rising investment in research development of new drugs will boost the market growth.

North America industry is predicted to dominate majority revenue share of 35% by 2037, driven by rising count of people living with ET in the region.

The major players in the market are Active Biotech AB, Incyte, Bayer AG, USV Private Limited., Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, AstraZeneca, Takeda Pharmaceutical Company Limited

Essential Thrombocythemia Market - Top Companies and Manufacturers

Companies Dominating the Essential Thrombocythemia Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the essential thrombocythemia market?

Why is the essential thrombocythemia sector gaining traction in near future?

Which region accounted for the largest essential thrombocythemia industry share?

Who are the major essential thrombocythemia players?